Precigen Inc.

Precigen, Inc. is a clinical‑stage biopharma focused on precision gene and CAR‑T therapies for oncology, autoimmune and infectious diseases. Its proprietary AdenoVerse and UltraCAR‑T platforms power pipeline assets in Phase I–II trials worldwide.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 143
HQ: Germantown

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
PGEN	Precigen Inc. Cap: 1.6B	EQUITY	NMS	USD	US74017N1054	Active	📈